About the Company
Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. Thomas Sandgaard founded Zynex Medical in 1996. The company is based in unincorporated Douglas County, Colorado. Thomas Sandgaard serves as the company's CEO.
Sector
Industrial Applications and Services
Industry
Electromedical & Electrotherapeutic Apparatus
Employees
891
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on ZYNEX INC
Zynex Appoints New CFO and CLO Amid Leadership Changes
Zynex ( (ZYXI) ) has issued an announcement. On August 18, 2025, Zynex, Inc. announced the appointment of Vikram Bajaj as Chief Financial Officer and John Bibb as Chief Legal Officer, as part of a ...
Zynex, Inc. (ZYXI) Craters 51% On Possible Accounting Issues ...
The suit, captioned Tuncel v. Zynex, Inc., et al., No. 1:25-cv-00913 (D. Colo.) seeks to represent investors who purchased Zynex securities between March 13, 2023 and March 11, 2025.
Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare ... - Morningstar
Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit – Hagens Berman Provided by GlobeNewswire Apr 3, 2025, 10:43:23 AM ...
Zynex, Inc. (ZYXI) Investors Who Lost Money Have Opportunity to Lead ...
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZYNEX, INC. (ZYXI), CLICK HERE BEFORE MAY 19, 2025 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
Zynex, Inc.: Zynex Announces Arrival of Steven Dyson as CEO and Appointment of New Leadership in Key Roles
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...
Law Offices of Howard G. Smith Encourages Zynex, Inc. (ZYXI) Investors ...
Zynex investors have until May 19, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ZYNEX, INC.
Zynex, Inc. (NASDAQ:ZYXI) Delivered A Weaker ROE Than Its Industry
Zynex clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.64. With a fairly low ROE, and significant use of debt, it's hard to get excited about this ...
Zynex, Inc.: 2025 Looks Like A Brighter Year - Seeking Alpha
Zynex, Inc. made 44 cents a share in FY2024 on just over $184 million in revenue. The current analyst firm consensus is for profits to decline to 20 cents a share in FY2024 even as sales rise to ...
Zynex Named as a Winner in the Deloitte 2022 Technology Fast 500TM ...
Contact: Zynex, Inc. (800) 495-6670 Investor Relations Contact: Gilmartin Group 650 Fifth Ave., Suite 2720 New York, NY 10019 ir@zynex.com ...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Zynex, Inc. Investors ...
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Zynex, Inc. Investors with Losses in Excess of $100K to Inquire About Class Action Investigation – ZYXI March 09, 2023 12:33 PM Eastern Standard Time ...
Zynex, Inc. (NASD: ZYXI) Wins 2023 National Top Workplaces Award in the ...
ENGLEWOOD, Colo., July 17, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for ...
Zynex, Inc. Just Recorded A 21% EPS Beat: Here's What Analysts Are ...
There's been a notable change in appetite for Zynex, Inc. (NASDAQ:ZYXI) shares in the week since its quarterly report, with the stock down 17% to US$13.89. Revenues were US$31m, approximately in ...
Similar Companies
Loading the latest forecasts...